These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8975752)

  • 1. Optimizing the review process of food additive and GRAS petitions. Legislative options and opportunities.
    Finley AM
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):240-1. PubMed ID: 8975752
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing the review process of food additive and GRAS petitions. Overview of the workshop.
    Hutt PB
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):242-5. PubMed ID: 8975753
    [No Abstract]   [Full Text] [Related]  

  • 3. Workshop "Optimizing the Review Process of Food Additive and GRAS Petitions", April 18, 1996. Welcoming remarks.
    Gori GB
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):213. PubMed ID: 8975746
    [No Abstract]   [Full Text] [Related]  

  • 4. Generally recognized as safe (GRAS): history and description.
    Burdock GA; Carabin IG
    Toxicol Lett; 2004 Apr; 150(1):3-18. PubMed ID: 15068820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food ingredient review at FDA: recent data and initiatives to improve the process.
    Rulis AM; Tarantino LM
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):224-31. PubMed ID: 8975749
    [No Abstract]   [Full Text] [Related]  

  • 6. Food contact substances and the need for food safety reform.
    Heckman JH
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):236-9. PubMed ID: 8975751
    [No Abstract]   [Full Text] [Related]  

  • 7. Origins and causes of the problem: the regulatory context.
    Merrill RA
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):214-7. PubMed ID: 8975747
    [No Abstract]   [Full Text] [Related]  

  • 8. Rebooting the generally recognized as safe (GRAS) approach for food additive safety in the US.
    Hartung T
    ALTEX; 2018; 35(1):3-25. PubMed ID: 29374436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macronutrient substitutes: are regulatory options possible?
    Degnan FH
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S38-41. PubMed ID: 8801616
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance.
    Neltner TG; Alger HM; O'Reilly JT; Krimsky S; Bero LA; Maffini MV
    JAMA Intern Med; 2013 Dec 9-23; 173(22):2032-6. PubMed ID: 23925593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-Intake Reduction and the Food Industry.
    Henney JE; O'Hara JA; Taylor CL
    N Engl J Med; 2019 Jul; 381(3):201-203. PubMed ID: 31141627
    [No Abstract]   [Full Text] [Related]  

  • 12. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 13. Food and Drug Administration regulation of medical device biotechnology, and food and food additive biotechnology.
    Kahan JS; Gibbs JN
    Appl Biochem Biotechnol; 1985 Dec; 11(6):507-16. PubMed ID: 3914237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GRAS provision - The FEMA GRAS program and the safety and regulation of flavors in the United States.
    Hallagan JB; Hall RL; Drake J
    Food Chem Toxicol; 2020 Apr; 138():111236. PubMed ID: 32135216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FEMA GRAS--a GRAS assessment program for flavor ingredients. Flavor and Extract Manufacturers Association.
    Hallagan JB; Hall RL
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):422-30. PubMed ID: 7480896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Delaney Clause at the FDA.
    Lorentzen RJ
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):198. PubMed ID: 8672876
    [No Abstract]   [Full Text] [Related]  

  • 17. GRAS: time-tested, and trusted, food ingredients.
    Rados C
    FDA Consum; 2004; 38(2):20-1. PubMed ID: 15101360
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives on immunotoxicity regulatory guidelines.
    Harling RJ
    Inflamm Res; 1996 Dec; 45 Suppl 2():S69-73. PubMed ID: 8988405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food Additives and Child Health.
    Trasande L; Shaffer RM; Sathyanarayana S;
    Pediatrics; 2018 Aug; 142(2):. PubMed ID: 30037974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The logistical requirements of current FDA review: format of documentation requested.
    Hattan D
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):232-5. PubMed ID: 8975750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.